Literature DB >> 1630607

Radiological study of the brain at various stages of human immunodeficiency virus infection: early development of brain atrophy.

R Raininko1, I Elovaara, A Virta, L Valanne, M Haltia, S L Valle.   

Abstract

One hundred and one persons infected with human immunodeficiency virus (HIV-1), in whom other central nervous system infections or diseases were excluded, underwent brain CT and/or MRI at various stages of HIV-1 infection: 29 were asymptomatic (ASX), 35 had lymphadenopathy syndrome (LAS), 17 had AIDS-related complex (ARC), and 20 had AIDS. A control group of 32 HIV-1-seronegative healthy persons underwent brain MRI. The most common finding was brain atrophy, found in 9% of controls, and 31% of ASX cases, 29% of LAS, 59% of ARC and 70% of AIDS. Even the difference between the ASX or LAS groups and controls was significant. The changes were bilateral and symmetrical, and they were more severe at later stages of infection. Infratentorial atrophy was seen in the early stages; supratentorial atrophy became more pronounced at ARC, and generalized atrophy was typical of AIDS. Non-specific small hyperintense foci were found on MRI in 13% of controls and 6-15% of the infected groups. Larger, diffuse, bilateral white matter infiltrates were detected in 4 demented patients with AIDS. Four patients with AIDS and 1 with LAS had focal hyperintense lesions in the internal capsules, lentiform nuclei or thalamus, often bilateral on MRI. One patient with AIDS, examined with CT only, had low density in the lentiform nucleus. Loss of brain parenchyma can occur at an early stage of HIV-1 infection, and the atrophic process becomes more intense at later stages (ARC and AIDS). Parenchymal infiltration, seen as hyperintense areas on MRI, is most often associated with severe clinical symptoms, in the later stages of the disease.

Entities:  

Mesh:

Year:  1992        PMID: 1630607     DOI: 10.1007/bf00596333

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  46 in total

1.  Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation.

Authors:  H S Chrysikopoulos; G A Press; M R Grafe; J R Hesselink; C A Wiley
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

2.  CT of acquired immunodeficiency syndrome.

Authors:  E M Bursztyn; B C Lee; J Bauman
Journal:  AJNR Am J Neuroradiol       Date:  1984 Nov-Dec       Impact factor: 3.825

3.  [Brain involvement in acquired immunodeficiency syndrome (AIDS): computed tomography (CT) and magnetic resonance tomography (MR)].

Authors:  G P Krestin; R Jürgens; W Steinbrich; N Diederich
Journal:  Rofo       Date:  1986-12

4.  CT, MR, and pathology in HIV encephalitis and meningitis.

Authors:  M J Post; L G Tate; R M Quencer; G T Hensley; J R Berger; W A Sheremata; G Maul
Journal:  AJR Am J Roentgenol       Date:  1988-08       Impact factor: 3.959

5.  Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells.

Authors:  T Kato; A Hirano; J F Llena; H M Dembitzer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  White matter disease in AIDS: findings at MR imaging.

Authors:  W L Olsen; F M Longo; C M Mills; D Norman
Journal:  Radiology       Date:  1988-11       Impact factor: 11.105

7.  Acquired immunodeficiency syndrome: neuroradiologic findings.

Authors:  W M Kelly; M Brant-Zawadzki
Journal:  Radiology       Date:  1983-11       Impact factor: 11.105

8.  Neurologic complications in acquired immunodeficiency syndrome (AIDS).

Authors:  C B Britton; J R Miller
Journal:  Neurol Clin       Date:  1984-05       Impact factor: 3.806

9.  Early penetration of the blood-brain-barrier by HIV.

Authors:  L Resnick; J R Berger; P Shapshak; W W Tourtellotte
Journal:  Neurology       Date:  1988-01       Impact factor: 9.910

10.  Cerebral computed tomography in men with acquired immunodeficiency syndrome.

Authors:  B Brun; F Boesen; J Gerstoft; J O Nielsen; J Praestholm
Journal:  Acta Radiol Diagn (Stockh)       Date:  1986 Jul-Aug
View more
  5 in total

1.  Cognitive reserve protects against apathy in individuals with human immunodeficiency virus.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Deena Peyser; Barry S Zingman; Joe Verghese
Journal:  Arch Clin Neuropsychol       Date:  2013-09-09       Impact factor: 2.813

2.  Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.

Authors:  Clayton A Wiley; Brian J Lopresti; James T Becker; Fernando Boada; Oscar L Lopez; John Mellors; Carolyn C Meltzer; Stephen R Wisniewski; Chester A Mathis
Journal:  J Neurovirol       Date:  2006-08       Impact factor: 2.643

3.  Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course.

Authors:  M M Thurnher; E G Schindler; S A Thurnher; H Pernerstorfer-Schön; C Kleibl-Popov; A Rieger
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

4.  PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS.

Authors:  Sriram Venneti; Brian J Lopresti; Guoji Wang; Stephanie J Bissel; Chester A Mathis; Carolyn C Meltzer; Fernando Boada; Saverio Capuano; Geraldine J Kress; Denise K Davis; James Ruszkiewicz; Ian J Reynolds; Michael Murphey-Corb; Anita M Trichel; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

5.  Untreated Patients Dying With AIDS Have Loss of Neocortical Neurons and Glia Cells.

Authors:  Sanne Simone Kaalund; Annette Johansen; Katrine Fabricius; Bente Pakkenberg
Journal:  Front Neurosci       Date:  2020-01-15       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.